Rifat Atun sits on the Movement Health Global Board, which offers expert insights into healthcare inequality and helps to steer Movement Health 2030 towards ensuring fairer access to better healthcare for all. He has worked with more than 30 governments globally, the World Bank, and the World Health Organization, and the UK Department for International Development to design, implement and evaluate health system reform initiatives.
Professor Atun has led executive programs and assignments for companies including Novartis, Medtronic, GSK, Pfizer Inc., the Vodafone Group, Hofmann La Roche, and Tata Consulting Services.
His research focuses on the design and implementation of health systems reforms and their impact on outcomes. His research also explores adoption and diffusion of innovations in health systems, e.g. health technologies, disease control programmes, and primary healthcare reforms, and innovative financing in global health.